Mayra Matesanz
YOU?
Author Swipe
View article: Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review Open
Community-acquired pneumonia represents the third-highest cause of mortality in industrialized countries and the first due to infection. Although guidelines for the approach to this infection model are widely implemented in international h…
View article: COVID-19 in donation and transplant
COVID-19 in donation and transplant Open
SARS-CoV-2 infection has had a major impact on donation and transplantation. Since the cessation of activity two years ago, the international medical community has rapidly generated evidence capable of sustaining and increasing this necces…
View article: Ceftolozane-tazobactam in nosocomial pneumonia
Ceftolozane-tazobactam in nosocomial pneumonia Open
Ceftolozane is a potent antimicrobial against Pseudomonas aeruginosa, including carbapenem-resistant and multidrug-resistant strains, and is also active against Enterobacteriaceae. It MIC (minimal inhibitory concentration) and MPC (mutant …
View article: Ceftazidime-avibactam
Ceftazidime-avibactam Open
Ceftazidime is a 3rd generation cephalosporin active against Pseudomonas aeruginosa. Avibactam is an inhibitor of class A, C and some class D β-lactamases. The antibacterial spectrum of ceftazidime-avibactam covers 95% of P. aeruginosa iso…
View article: Dalbavancin was effective and safe after one year of treatment in a complicated osteoarticular infection caused by methicillin-resistant Staphylococcus aureus
Dalbavancin was effective and safe after one year of treatment in a complicated osteoarticular infection caused by methicillin-resistant Staphylococcus aureus Open
Under treatment with lacosamide, phenobarbital, prokinetics, laxatives for constitutional constipation and protein supplements.From July 2018 to March 2019 the patient developed up to four episodes of fever, lumbar pain, right coxalgia, wo…
View article: Current aspects in sepsis approach. Turning things around.
Current aspects in sepsis approach. Turning things around. Open
The incidence and prevalence of sepsis depend on the definitions and records that we use and we may be underestimating their impact. Up to 60% of the cases come from the community and in 30-60% we obtain microbiological information. Someti…
View article: [Antibiotic diffusion to central nervous system].
[Antibiotic diffusion to central nervous system]. Open
Central nervous system (CNS) infections caused by pathogens with a reduced sensitivity to drugs are a therapeutic challenge. Transport of fluid and solutes is tightly controlled within CNS, where vasculature exhibits a blood-brain barrier …